Caitong International Asset Management’s Cumberland Pharmaceuticals CPIX Stock Holding History

Caitong International Asset Management’s Portfolio CPIX Stock Details CPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6	Buy	+2	New	+$8	﹤0.01%	2226

Other funds holding CPIX

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Caitong International Asset Management's CPIX Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in Cumberland Pharmaceuticals (CPIX) in Q1 2026: 2 shares worth $6. The stake represents ﹤0.01% of the portfolio and ranks #2226 among its holdings.

29 funds tracked by Wall St. Rank hold CPIX as of Q1 2026.

Caitong International Asset Management held 2 shares of Cumberland Pharmaceuticals worth $6 as of Q1 2026.
Cumberland Pharmaceuticals was a new Caitong International Asset Management position in Q1 2026.
Cumberland Pharmaceuticals made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #2226 holding.
29 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.